Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
The Terasaki Innovation Center currently has 1 pending office action within its patent portfolio. This prosecution activity involves 1 distinct examiner, identified as MONTGOMERY, ANN Y. The data shows 0 distinct art units associated with this portfolio, which suggests the current matters may be in a preliminary or transitional state.
MONTGOMERY, ANN Y serves as the busiest examiner for the portfolio, handling 1 busiest examiner pending office action. Because the total number of 1 pending office action is assigned to this individual, the examiner is responsible for the entirety of the center's current pending prosecution. The involvement of 1 distinct examiner indicates that the portfolio's immediate legal trajectory is determined by this point of review.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MONTGOMERY, ANN Y | 1 | 69.0% | +27.7% |
| HOWARD, ZACHARY C | 1 | 64.0% | +37.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18264013 | METHODS AND MATERIALS FOR IMPROVED IMMUNOASSAYS USING SYNTHETIC ANTIGENS | HOWARD, ZACHARY C | 70d |
| 18435898 | IMMUNOLOGICAL METHODS INVOLVING DRA:DQB AND DPA:DQB HETERODIMERS | MONTGOMERY, ANN Y | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18264013 | METHODS AND MATERIALS FOR IMPROVED IMMUNOASSAYS USING SYNTHETIC ANTIGENS | HOWARD, ZACHARY C | 70d |
| 18435898 | IMMUNOLOGICAL METHODS INVOLVING DRA:DQB AND DPA:DQB HETERODIMERS | MONTGOMERY, ANN Y | — |
| Art Unit | Apps |
|---|---|
| 1674 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18435898 | IMMUNOLOGICAL METHODS INVOLVING DRA:DQB AND DPA:DQB HETERODIMERS | MONTGOMERY, ANN Y | — | §101§102§103§112 | Non-Final OA | — | Pending | Feb 07, 2024 |
| 18264013 | METHODS AND MATERIALS FOR IMPROVED IMMUNOASSAYS USING SYNTHETIC ANTIGENS | HOWARD, ZACHARY C | 1674 | §102§103§112 | Final Rejection | 70d | Pending | Aug 02, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial